Fund Holdings — Catalio Capital Management, LP

Total Portfolio Value
$403.35M
Total Bought
$131.05M
Total Sold
$165.77M
Net Transaction
-$34.71M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
SYNDAX PHARMACEUTICALS INC(SNDX)01,733,701+1,733,701021,2995.28%+21,299
ELI LILLY & CO(LLY)023,682+23,682019,5594.85%+19,559
INSPIRE MED SYS INC(INSP)085,877+85,877013,6783.39%+13,678
BECTON DICKINSON & CO(BDX)148,615203,965+55,35033,71646,72011.58%+13,004
SOLENO THERAPEUTICS INC0160,962+160,962011,5012.85%+11,501
BRIDGEBIO PHARMA INC(BBIO)898,458962,883+64,42524,65433,2878.25%+8,633
REGENERON PHARMACEUTICALS(REGN)012,261+12,26107,7761.93%+7,776
EDWARDS LIFESCIENCES CORP333,144435,588+102,44424,66331,5717.83%+6,909
SPRINGWORKS THERAPEUTICS INC764,668758,533-6,13527,62733,4748.30%+5,847
ADAPTIVE BIOTECHNOLOGIES COR(ADPT)0611,639+611,63904,5441.13%+4,544
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)0114,616+114,61604,4781.11%+4,478
VIR BIOTECHNOLOGY INC(VIR)0611,608+611,60803,9630.98%+3,963
REPLIMUNE GROUP INC(REPL)0355,640+355,64003,4670.86%+3,467
VERACYTE INC(VCYT)490,547762,225+271,67819,42622,6005.60%+3,174
CYTOKINETICS INC(CYTK)457,587585,812+128,22521,52523,5445.84%+2,019
OUTSET MED INC(OM)0166,666+166,66601,8430.46%+1,843
ZENAS BIOPHARMA INC(ZBIO)187,184295,148+107,9641,5332,3320.58%+799
ASCENDIS PHARMA A/S(ASND)215,587195,523-20,06429,68030,4747.56%+794
FULCRUM THERAPEUTICS INC(FULC)0202,139+202,13905820.14%+582
KARYOPHARM THERAPEUTICS INC(KPTI)0155,622+155,62205820.14%+582
ATAI LIFE SCIENCES NV196,858196,85802622680.07%+6
SENSEI BIOTHERAPEUTICS INC(FTH)294,374294,37401441160.03%-28
HYPERFINE INC(HYPR)760,035760,03506695440.13%-124
FRACTYL HEALTH INC(GUTS)214,236214,23604412550.06%-186
KYVERNA THERAPEUTICS INC(KYTX)586,909586,90902,1951,1330.28%-1,062
PROTARA THERAPEUTICS INC(TARA)1,088,6911,088,69105,7484,6381.15%-1,110
INTUITIVE SURGICAL INC36,91036,499-41119,26618,0774.48%-1,189
METAGENOMI INC(MGX)528,993528,99301,9107190.18%-1,190
KARYOPHARM THERAPEUTICS INC(KPTI)2,334,3750-2,334,3751,5790—-1,579
MERSANA THERAPEUTICS INC1,705,0361,705,03602,4385870.15%-1,851
KEROS THERAPEUTICS INC(KROS)407,292389,384-17,9086,4473,9680.98%-2,480
DIANTHUS THERAPEUTICS INC(DNTH)763,471763,471016,64413,8493.43%-2,794
STRUCTURE THERAPEUTICS INC569,395704,864+135,46915,44212,2013.02%-3,241
BOSTON SCIENTIFIC CORP(BSX)72,9250-72,9256,5140—-6,514
INARI MED INC132,5450-132,5456,7660—-6,766
UNIQURE NV(QURE)901,973830,325-71,64815,9298,8012.18%-7,127
LIVANOVA PLC(LIVN)512,447381,648-130,79923,73114,9913.72%-8,740
ADMA BIOLOGICS INC512,7240-512,7248,7930—-8,793
DISC MEDICINE INC(IRON)179,8150-179,81511,4000—-11,400
MASIMO CORP87,3770-87,37714,4430—-14,443
EXACT SCIENCES CORP(EXK)309,1030-309,10317,3680—-17,368
SEPTERNA INC(SEPN)1,024,2451,024,245023,4555,9301.47%-17,525
ENVISTA HOLDINGS CORPORATION(NVST)1,019,5290-1,019,52919,6670—-19,667
BLUEPRINT MEDICINES CORP284,6540-284,65424,8280—-24,828
BRISTOL-MYERS SQUIBB CO(BMY)499,1510-499,15128,2320—-28,232
Page 1 of 1
Catalio Capital Management, LP — 13F Holdings — Q1 2025 | TickerTrail